Track: Hypertension and Stroke

Cardio Care Conference 2025

The "Hypertension and Stroke" session will delve into the critical connection between hypertension and stroke, highlighting the latest advancements in prevention, diagnosis, and treatment. It will explore innovative diagnostic tools that allow for early detection of high blood pressure, enabling timely interventions to reduce stroke risk. The session will also focus on cutting-edge therapies, including medications and lifestyle modifications, that are revolutionizing the management of hypertension. By addressing both the prevention and treatment of stroke in hypertensive patients, this session will offer a comprehensive approach to improving long-term health and reducing the global burden of stroke.

Hypertension as a Leading Risk Factor for Stroke: Explore how sustained high blood pressure accelerates the process of atherosclerosis and weakens blood vessels, increasing the likelihood of both ischemic and hemorrhagic strokes.

Stroke Pathophysiology and Classification: Understand the two main types of stroke—ischemic and hemorrhagic—by examining the underlying mechanisms, including blood clots blocking arteries and blood vessels rupturing. Insights into stroke classifications help in tailoring preventive strategies.

Early Detection and Intervention Strategies for Stroke: Gain insights into diagnostic tools and techniques for identifying stroke risk in hypertensive patients. Early detection methods, such as regular blood pressure monitoring and imaging, are essential for preventing stroke.

Rehabilitation and Post-Stroke Care in Hypertensive Patients: Discover how post-stroke care, including rehabilitation strategies and blood pressure control, can enhance recovery and reduce the risk of subsequent strokes in hypertensive patients.

Pulmonary Hypertension and Right Heart Failure: Dive into the diagnosis, management, and treatment of pulmonary hypertension, a critical condition often leading to right heart failure. Discuss current pharmacological treatments, such as vasodilators and endothelin receptor antagonists, and their role in improving quality of life for affected patients.